The successful immunogenicity and safety results of ETVAX® are presented at Vaccines for Enteric Diseases (VED) Oct 16-18 in Lausanne, Switzerland
Today we will present the excellent results from multiple completed and on-going clinical trials of ETVAX® at VED - a conference that addresses the diverse aspects of vaccines to counter human enteric diseases. In the light of global public health issues, enteric diseases are estimated to be the top cause of infectious morbidity and the second leading cause of infectious mortality worldwide.